ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag animal rights disease medicine immunology

A bat flying in a dark cave
Turning on the Bat Signal
Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read
Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.
3D illustration of damaged myelin sheath seen in demyelinating diseases such as multiple sclerosis.
Tracking Down Innate Immune Cells in Multiple Sclerosis
Mariella Bodemeier Loayza Careaga, PhD | Dec 4, 2023 | 5 min read
A novel PET tracer targeting a receptor in myeloid cells can help monitor disease progression in a mouse model of multiple sclerosis.
A person lying on a bed checks the reading on a digital thermometer. A table with a bowl of oranges and various medications is in the background.
How Mild Is Omicron Really?
Dan Robitzski | Jan 14, 2022 | 9 min read
Early reports that Omicron causes less-severe disease than Delta seem to be borne out, but it’s not yet clear to what extent that’s due to the variant itself versus the populations it’s infecting.
bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
A close up shot of a thumb pointing to a pimple on a patch of bare skin
Skin Cells Can Transform To Help Fight Acne
Dan Robitzski | Mar 2, 2022 | 5 min read
A new study reveals that the fibroblasts in tissue surrounding acne infections play an active role in the body’s immune response—and that existing treatments help trigger them to do so.
The Vaginal Microbiome is Finally Getting Recognized
Hannah Thomasy, PhD, Drug Discovery News | Sep 25, 2023 | 10+ min read
Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women's health.
Immunology
The Scientist Staff | Sep 15, 1996 | 3 min read
Edited by: Karen Young Kreeger MAKING A MIGHTY MOUSE: Yale's Richard Flavell and coworkers developed a CD40 ligand-less knockout mouse. J.C. Xu, T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. ore, R.J. Noelle, R.A. Flavell, "Mice deficient for the CD40 ligand," Immunity, 1:423-31, 1994 (Cited in more than 80 publications as of August 1996) Comments by Richard A. Flavell, Howard Hughes Medical Institute, Yale University School of Medicine To more closely investigate the
Vet giving vaccines to pigs
Antimicrobial Resistance: The Silent Pandemic
Danielle Gerhard, PhD | Jun 30, 2023 | 9 min read
Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.
3d rendered medically accurate illustration of a human embryo anatomy
The Ephemeral Life of the Placenta
Danielle Gerhard, PhD | Dec 4, 2023 | 10+ min read
Recent advances in modeling the human placenta, the least understood organ, may inform placental disorders like preeclampsia.
Panels showing different kinds of microglia
Mapping Tool Reveals Microglia’s Shape-Shifting Secrets
Angie Voyles Askham, Spectrum | Dec 14, 2022 | 4 min read
The approach could help test hypotheses about how atypical function of the brain’s immune cells contributes to autism.

Run a Search

ADVERTISEMENT